These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 1722549)
1. Effects of recombinant human granulocyte and granulocyte-macrophage colony-stimulating factors on neutrophil function following autologous bone marrow transplantation. Gadish M; Kletter Y; Flidel O; Nagler A; Slavin S; Fabian I Leuk Res; 1991; 15(12):1175-82. PubMed ID: 1722549 [TBL] [Abstract][Full Text] [Related]
2. Effect of exogenous recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor on neutrophil function following allogeneic bone marrow transplantation. Fabian I; Kletter Y; Bleiberg I; Gadish M; Naparsteck E; Slavin S Exp Hematol; 1991 Oct; 19(9):868-73. PubMed ID: 1716591 [TBL] [Abstract][Full Text] [Related]
3. In vivo administration of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor increases neutrophil oxidative burst activity. Wiltschke C; Krainer M; Nanut M; Wagner A; Linkesch W; Zielinski CC J Interferon Cytokine Res; 1995 Mar; 15(3):249-53. PubMed ID: 7584671 [TBL] [Abstract][Full Text] [Related]
4. Effects of human interleukin 3, macrophage and granulocyte-macrophage colony-stimulating factor on monocyte function following autologous bone marrow transplantation. Fabian I; Shapira E; Gadish M; Kletter Y; Nagler A; Flidel O; Slavin S Leuk Res; 1992; 16(6-7):703-9. PubMed ID: 1321933 [TBL] [Abstract][Full Text] [Related]
5. Comparison of neutrophil and monocyte function by microbicidal cell-kill assay in patients with cancer receiving granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, or no cytokine after cytotoxic chemotherapy: a phase II trial. Nemunaitis J; Cox J; Meyer W; Courtney A; Hanson T; Green-Weaver C; Agosti J Am J Clin Oncol; 1998 Jun; 21(3):308-12. PubMed ID: 9626806 [TBL] [Abstract][Full Text] [Related]
6. Differential effects of granulocyte- and granulocyte-macrophage colony-stimulating factors (G- and GM-CSF) on neutrophil adhesion in vitro and in vivo. Yong KL; Linch DC Eur J Haematol; 1992 Nov; 49(5):251-9. PubMed ID: 1282108 [TBL] [Abstract][Full Text] [Related]
7. Granulocyte and granulocyte-macrophage colony-stimulating factors for treatment of neutropenia in glycogen storage disease type Ib. Schroten H; Roesler J; Breidenbach T; Wendel U; Elsner J; Schweitzer S; Zeidler C; Burdach S; Lohmann-Matthes ML; Wahn V J Pediatr; 1991 Nov; 119(5):748-54. PubMed ID: 1719175 [TBL] [Abstract][Full Text] [Related]
8. Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies. Vose JM; Bierman PJ; Ruby E; Reed EC; Bishop MR; Tarantolo S; Kessinger A; Armitage JO Bone Marrow Transplant; 1996 Jun; 17(6):951-6. PubMed ID: 8807099 [TBL] [Abstract][Full Text] [Related]
9. Recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for malignant lymphoma: a British National Lymphoma Investigation double-blind, placebo-controlled trial. Khwaja A; Linch DC; Goldstone AH; Chopra R; Marcus RE; Wimperis JZ; Russell NH; Haynes AP; Milligan DW; Leyland MJ Br J Haematol; 1992 Oct; 82(2):317-23. PubMed ID: 1419813 [TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization. McCawley LJ; Korchak HM; Douglas SD; Campbell DE; Thornton PS; Stanley CA; Baker L; Kilpatrick L Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873 [TBL] [Abstract][Full Text] [Related]
11. Effects of recombinant human granulocyte colony-stimulating factor on neutrophil function in vitro and in vivo following chemotherapy and autologous bone marrow transplantation. Humphreys JM; Rugman FP; Davies JM; Mimnagh P; Hart CA; Edwards SW J Clin Lab Immunol; 1991 Feb; 34(2):55-61. PubMed ID: 1725883 [TBL] [Abstract][Full Text] [Related]
12. Effect of granulocyte-macrophage colony-stimulating factor on superoxide production in cytoplasts and intact human neutrophils: role of protein kinase and G-proteins. Mege JL; Gomez-Cambronero J; Molski TF; Becker EL; Sha'afi RI J Leukoc Biol; 1989 Aug; 46(2):161-8. PubMed ID: 2545809 [TBL] [Abstract][Full Text] [Related]
13. Increased respiratory burst activity of neutrophils in patients with aplastic anemia: effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. Ohsaka A; Kitagawa S; Yuo A; Motoyoshi K; Ohta M; Miura Y; Takaku F; Saito M Exp Hematol; 1992 Oct; 20(9):1090-3. PubMed ID: 1281785 [TBL] [Abstract][Full Text] [Related]
14. Retrospective analysis of infectious disease in patients who received recombinant human granulocyte-macrophage colony-stimulating factor versus patients not receiving a cytokine who underwent autologous bone marrow transplantation for treatment of lymphoid cancer. Nemunaitis J; Buckner CD; Dorsey KS; Willis D; Meyer W; Appelbaum F Am J Clin Oncol; 1998 Aug; 21(4):341-6. PubMed ID: 9708630 [TBL] [Abstract][Full Text] [Related]
15. Antibody to Mol abrogates the increase in neutrophil phagocytosis and degranulation induced by granulocyte-macrophage colony-stimulating factor. Kletter Y; Bleiberg I; Golde DW; Fabian I Eur J Haematol; 1989 Nov; 43(5):389-96. PubMed ID: 2482194 [TBL] [Abstract][Full Text] [Related]
16. Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hemopoietic stem cell transplantation for lymphoma. Advani R; Chao NJ; Horning SJ; Blume KG; Ahn DK; Lamborn KR; Fleming NC; Bonnem EM; Greenberg PL Ann Intern Med; 1992 Feb; 116(3):183-9. PubMed ID: 1345803 [TBL] [Abstract][Full Text] [Related]
17. Recombinant human G-CSF and GM-CSF prime human neutrophils for superoxide production through different signal transduction mechanisms. Balazovich KJ; Almeida HI; Boxer LA J Lab Clin Med; 1991 Dec; 118(6):576-84. PubMed ID: 1720802 [TBL] [Abstract][Full Text] [Related]
18. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation. Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941 [TBL] [Abstract][Full Text] [Related]
19. Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein versus granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for non-Hodgkin's lymphoma: results of a randomized double-blind trial. Vose JM; Pandite AN; Beveridge RA; Geller RB; Schuster MW; Anderson JE; LeMaistre CF; Ahmed T; Granena A; Keating A; Fernandez Ranada JM; Stiff PJ; Tabbara I; Longo W; Copelan EA; Nichols C; Smith A; Topolsky DL; Bierman PJ; Lebsack ME; Lange M; Garrison L J Clin Oncol; 1997 Apr; 15(4):1617-23. PubMed ID: 9193361 [TBL] [Abstract][Full Text] [Related]
20. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on respiratory burst activity of neutrophils in patients with myelodysplastic syndromes. Ohsaka A; Kitagawa S; Yuo A; Motoyoshi K; Furusawa S; Miura Y; Takaku F; Saito M Clin Exp Immunol; 1993 Feb; 91(2):308-13. PubMed ID: 7679062 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]